Jennifer Fitzpatrick
CLO and Head of Program Mgmt. · Sionna Therapeutics, Inc.
- 2025
- Sep 18, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer Fitzpatrick files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Bruce Booth - $18.23M in SION purchases and sales in the last 12 months
- TPG GP A, LLC - $10.00M in SION purchases and sales in the last 12 months
- Michael Cloonan - $4.41M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer Fitzpatrick?
Jennifer Fitzpatrick is a corporate insider, tracked as CLO and Head of Program Mgmt. of Sionna Therapeutics, Inc. (SION). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jennifer Fitzpatrick submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jennifer Fitzpatrick been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.03M) across all tracked filings.
